Rejected at 12:16 a.m. Jul, 04, 2025 ] by Ahmed7
Author: jollydolphin
Related Note: 1506457874779 1
Rationale for change

It's been two years since this card was changed to state that Nirsevimab is the preferred drug. This seems like a good time to change the answer, but retain the information in extra about the old drug that might still show up on tests.

Source: Other - Reshuffle information in the card

Rejection reason

Unless the new drug is tested in a question bank directly, then we can keep original for now

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Empty field
Additional Resources
Empty field
One by one
Empty field
#AK_Step2_v12::Original_decks::Dorian::peds::emma #AK_Step2_v12::!Shelf::Peds::no_dupes #AK_Step1_v12::#OME::Clinical::Internal_Medicine::Infectious_Disease::Pneumonia #AK_Step2_v12::#Bootcamp::Pediatrics::02_General_Pediatrics::01_Primary_Care::05_Vaccination #AK_Other::Only_Step_1&2_Overlap #AK_Step1_v12::#FirstAid::03_Microbiology::05_Virology::09_RNA_viruses #AK_Step2_v12::#Resources_by_rotation::Peds::emma #PANCE::EOR::PEDS #AK_Step1_v12::#Pixorize::04_Microbiology::08_Viruses-RNA_Viruses::24_Respiratory_Syncytial_Virus_(RSV) #AK_Step1_v12::#FirstAid::03_Microbiology::05_Virology::15_Paramyxoviruses #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#B&B::20_Pulm::03_Other_Pulmonary_Topics::02_Pneumonia_II #AK_Step1_v12::#UWorld::Step::1668 #AK_Step1_v12::#AMBOSS::Xaa9QQ #AK_Step1_v12::#Textbooks::#Mims_Microbiology::20_Lower_Respiratory_Tract_Infections #AK_Step1_v12::#Bootcamp::Microbiology::29_Negative-sense_RNA_Viruses::05_Respiratory_Syncytial_Virus #AK_Step1_v12::#SketchyMicro::03_Viruses::02_RNA_(-)_Sense::03_Respiratory_Syncytial_Virus_&_Human_Metapneumovirus_(Pneumoviridae) #PANCE::PULM::infectious_disorders #AK_Step2_v12::#SketchyPeds::09_Infectious_Diseases::03_Ear,_Nose,_Throat,_&_Respiratory_Infections::02_Bronchiolitis #AK_Step1_v12::#Physeo::06_Micro::05_Viruses::30_Respiratory_Syncytial_Virus_(RSV)_&_Human_Metapneumovirus_(hPMV) #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Bugs #AK_Step2_v12::#AMBOSS::gQ0Fvf #AK_Step1_v12::#SketchyMicro::03_Viruses::04_Retired_Lessons::09_Measles_virus,_mumps_virus,_respiratory_syncytial_virus,_parainfluenza_virus_(Paramyxoviridae)_[Retired_Video] #AK_Step1_v12::#FirstAid::02_Immunology::04_Immunosuppressants::03_Therapeutic_antibodies::*Palivizumab #AK_Step2_v12::#Bootcamp::Pediatrics::03_Infectious_Disease::02_Airway_and_Respiratory_Infections::01_Viral_Respiratory_Infections_in_Children #AK_Step1_v12::#AMBOSS::FjagXk #AK_Step2_v12::#AMBOSS::2DaTd5 #AK_Step1_v12::#UWorld::COMLEX::24779 #AK_Step1_v12::#Textbooks::#Mims_Microbiology::31_Infections_in_the_Compromised_Host